Onychomycosis: Recommendations for Diagnosis, Assessment of Treatment Efficacy, and Specialist Referral. The CONSONANCE Consensus Project

被引:6
作者
Piraccini, Bianca Maria [1 ]
Starace, Michela [1 ]
Rubin, Adam, I [2 ]
Di Chiacchio, Nilton Gioia [3 ,4 ]
Iorizzo, Matilde
Rigopoulos, Dimitris [5 ]
机构
[1] Univ Bologna, Dept Specialized Expt & Diagnost Med, Dermatol IRCCS, Alma Mater Studiorum,Policlin St Orsola, Bologna, Italy
[2] Univ Penn, Hosp Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Philadelphia, PA 19104 USA
[3] Fac Med ABC, Santo Andre, SP, Brazil
[4] Hosp Servidor Publ Municipal Sao Paulo, Sao Paulo, Brazil
[5] Natl & Kapodistrian Univ Athens, Fac Med, Dept Dermatol Venereol, Andreas Sygros Hosp, Athens, Greece
关键词
Antifungals; Consensus; Dermatophytes; Diagnosis; European Nail Society; Onychomycosis; Primary care; Referral; Treatment; QUALITY-OF-LIFE; DERMATOLOGISTS; IMPACT;
D O I
10.1007/s13555-022-00698-x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Introduction Onychomycosis is the most common nail disorder in adults, with high recurrence and relapse rates. Its diagnosis may be difficult by non-experts because the clinical signs may overlap with other dermatoses. The treatment may be challenging, as it should be patient-tailored. Methods An online survey was conducted among European Nail Society (ENS) members to provide recommendations on the diagnosis and assessment of distal lateral subungual onychomycosis (DLSO) in non-specialized clinical environments, as well as recommendations for patient referral. Results DLSO diagnosis is predominantly based on clinical aspects, and microscopy and fungal culture are commonly employed to establish the diagnosis. Assessment of clinical features is the main method for DLSO follow-up, and the main criterion to define cure is a combination of mycologic cure and clinical cure. The most commonly selected treatments for onychomycosis include oral antifungals, topical antifungals, and nail debridement. According to the nail experts, predisposing factors of DLSO to be evaluated include concurrent tinea pedis diagnosis, immunocompromised status, and diabetes. The minimum clinical aspects to be evaluated for DLSO diagnosis should include subungual hyperkeratosis, white-yellow-orange subungual scales, and absence of salmon-pink coloration. Recommendations for clinical signs that should be evaluated to confirm treatment effectiveness include normal appearance and color of the nail, reduction or absence of scales under the nail, and absence of onycholysis. Recommendations for specialist referral include lack of treatment effectiveness, need of additional therapies, concurrent presence of other diseases or comorbidities, severe DLSO, and presence of a dermatophytoma or involvement of the nail matrix. Conclusions According to the surveyed nail experts, after evaluating clinical signs and predisposing factors for DLSO, the diagnosis should include subungual hyperkeratosis, nail color (yellow-orange), and onycholysis and thickening. In cases of severe DLSO, when there is treatment failure, concomitant diseases/comorbidities, presence of a dermatophytoma or involvement of the nail matrix, or involvement of several/all nails, referral should be considered.
引用
收藏
页码:885 / 898
页数:14
相关论文
共 24 条
  • [1] British Association of Dermatologists' guidelines for the management of onychomycosis 2014
    Ameen, M.
    Lear, J. T.
    Madan, V.
    Mustapa, M. F. Mohd
    Richardson, M.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 (05) : 937 - 958
  • [2] American Academy of Dermatology (AAD), 2015, 10 THINGS PHYS PAT S
  • [3] Challenges and Opportunities in the Management of Onychomycosis
    Christenson, Julia K.
    Peterson, Gregory M.
    Naunton, Mark
    Bushell, Mary
    Kosari, Sam
    Baby, Kavya E.
    Thomas, Jackson
    [J]. JOURNAL OF FUNGI, 2018, 4 (03)
  • [4] Effect of onychomycosis on quality of life
    Drake, LA
    Scher, RK
    Smith, EB
    Faich, GA
    Smith, SL
    Hong, JJ
    Stiller, MJ
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1998, 38 (05) : 702 - 704
  • [5] The impact of onychomycosis on quality of life:: Development of an international onychomycosis-specific questionnaire to measure patient quality of life
    Drake, LA
    Patrick, DL
    Fleckman, P
    André, J
    Baran, R
    Haneke, E
    Sapède, C
    Tosti, A
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1999, 41 (02) : 189 - 196
  • [6] Elewski Boni E, 2015, J Clin Aesthet Dermatol, V8, P38
  • [7] A practical application of onychomycosis cure - combining patient, physician and regulatory body perspectives
    Gupta, A. K.
    Versteeg, S. G.
    Shear, N. H.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 (02) : 281 - 287
  • [8] The prevalence of culture-confirmed toenail onychomycosis in at-risk patient populations
    Gupta, A. K.
    Daigle, D.
    Foley, K. A.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2015, 29 (06) : 1039 - 1044
  • [9] The Impact of Onychomycosis on Quality of Life: A Systematic Review of the Available Literature
    Gupta, Aditya K.
    Mays, Rachel R.
    [J]. SKIN APPENDAGE DISORDERS, 2018, 4 (04): : 208 - 216
  • [10] Confirmatory Testing Prior to Initiating Onychomycosis Therapy Is Cost-Effective
    Gupta, Aditya K.
    Versteeg, Sarah G.
    Shear, Neil H.
    [J]. JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2018, 22 (02) : 129 - 141